U.S. Markets open in 9 hrs 25 mins

CTLT Jan 2023 105.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
16.230.00 (0.00%)
As of 09:30AM EDT. Market open.
Full screen
Previous Close16.23
Expire Date2023-01-20
Day's Range16.23 - 16.23
Contract RangeN/A
Open Interest1
  • Zacks

    Why Is Catalent (CTLT) Down 18.5% Since Last Earnings Report?

    Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Benzinga

    As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster

    The FDA authorized an additional five batches of Moderna Inc's (NASDAQ: MRNA) updated Covid booster shots made at Catalent Inc's (NYSE: CTLT) Indiana facility after it deemed them safe for use. Last week, the agency allowed the use of ten batches of Moderna's updated booster shots made at the Bloomington facility, owned by a unit of Catalent, which is currently not a part of emergency use authorization. Reuters reported that the FDA had earlier said Moderna had requested authorization for additi

  • Reuters

    UPDATE 1-U.S. delivers over 25 mln COVID boosters; Moderna's shot in limited supply

    The United States government has sent out over 25 million of the updated COVID-19 booster shots, mostly from Pfizer/BioNTech, as production of the Moderna shot continues to ramp up, a federal health agency said on Tuesday. Some U.S. pharmacies like CVS Health and Walgreens Boots Alliance also reported on Tuesday that government supply of Moderna's updated shot remains limited, causing appointments for the product to vary across the country. In a statement late on Tuesday, the U.S. Food and Drug Administration (FDA) said it authorized ten batches of Moderna's updated booster shots made at a Catalent facility in Indiana after it deemed them safe to use.